Experts Convene in Mexico City for International Symposium on Rotavirus (series of four releases)

Mexico City, July 7, 2004 (PAHO)—Rotavirus "is a major, major public health priority" for Mexico and for the Americas, Mexican Health Minister Dr. Julio Frenk said today at the opening of a global symposium on rotavirus, where health experts will spend three days discussing the latest information about the deadly disease.

international Rotavirus

Sabin Vaccine Institute Honors DNA Scientist James Watson and Biotechnology Pioneer Chiron at Annual Benefit Event

NEW CANAAN, CT—The Sabin Vaccine Institute will celebrate a Salute to Life-Saving Discoveries during its benefit dinner at The Pierre Hotel in New York City May 12. The evening will feature the presentation of awards to Nobel laureate James D. Watson, PhD, and to Howard Pien, president and CEO of Chiron Corporation.

Sabin

Fifty Years of Miracles: H.R. Shepherd and Peter J. Hotez Recall the Legacy of Vaccine Advances

NEW CANAAN, Conn., April 27 — Fifty years ago, six-year-old Randy Kerr from McLean, Virginia, was officially designated the nation's first child to be vaccinated with an experimental polio vaccine developed by Jonas Salk in his University of Pittsburgh laboratory. Over the next several months thousands of children who became known as "Polio Pioneers" stepped up to receive their polio injections as part of an enormous vaccine field trial.

Sabin

Former CDC Immunization Program Director Joins Board of Sabin Vaccine Institute

NEW CANAAN, CT—The Board of Trustees of the Albert B. Sabin Vaccine Institute announced the election of their newest board member, Walter Orenstein, MD. Recently recruited as Professor of Medicine and Pediatrics at Emory University School of Medicine, Dr. Orenstein’s posts at Emory will include director of the Program for Vaccine Policy and Development and associate director of the Vaccine Center. Dr.

Sabin

Researchers to Meet on Cutting-edge Cancer Vaccine Development at 2004 Colloquium on Cancer Vaccines and Immunotherapy

NEW CANAAN, CT— Approximately forty of the world’s leading cancer vaccine researchers will meet this week at a scientific colloquium organized by the Albert B. Sabin Vaccine Institute. Convening in think-tank sessions, they will report on the latest developments in this promising field of therapy focused on stimulation of the body’s immune system to attack existing cancerous cells.

Sabin

Sabin Vaccine Institute a Sponsor of the 2nd Biodefense Vaccines, Therapeutics and Diagnostics Conference

The U.S. Government's commitment to rapidly develop biomedical countermeasures against bioterrorist threats has stimulated a tremendous boost to biodefense research, a big push to expand research resources and facilities, and a growing dedication to build a robust biodefense industry.

Sabin

Sabin Institute Scientist Receives Tropical Medicine Medal

PHILADELPHIA, PA, December 3, 2003—Hartford, Connecticut native Peter J. Hotez, MD, PhD, FAAP claimed the 2003 Bailey K. Ashford Medal here today at the centenary meeting of the American Society of Tropical Medicine and Hygiene. Hotez is chairman of Microbiology and Tropical Medicine, The George Washington University, and senior fellow of the Albert Sabin Vaccine Institute, headquartered in New Canaan, Connecticut.

Sabin

Pages

Subscribe to RSS - Vaccine Advocacy and Education